Ascendis Pharma A/S (ASND) Q2 2023 Earnings

5SepConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-3.78
-3.23
-2.68
-2.13

Details

Expected EPS
-2.68
Actual EPS
-2.35
Surprise EPS
0.33
Surprise Percent
+12.31%

Description

Ascendis Pharma A/S (ASND) has reported earnings of -2.35 per share for Q2 2023.

0 Comments

Share your thoughts